Tetratherix Ltd.
Tetratherix Ltd. (TTX.AX) Stock Competitors & Peer Comparison
See (TTX.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TTX.AX | A$5.09 | +27.89% | 211.2M | -10.40 | -A$0.40 | N/A |
| RMD.AX | A$32.83 | -0.94% | 48B | 23.06 | A$1.43 | +1.06% |
| FPH.AX | A$31.75 | -0.38% | 18.8B | 52.38 | A$0.61 | +1.31% |
| ANN.AX | A$29.84 | +0.13% | 4.3B | 22.71 | A$1.31 | +2.70% |
| NAN.AX | A$3.40 | -3.13% | 1B | 49.43 | A$0.07 | N/A |
| SDI.AX | A$1.26 | +0.40% | 149.2M | 12.55 | A$0.10 | +2.71% |
| AHC.AX | A$0.38 | +0.00% | 144.3M | 19.25 | A$0.02 | N/A |
| TRJ.AX | A$0.46 | -8.08% | 70.9M | -46.50 | -A$0.01 | N/A |
| OSX.AX | A$0.01 | -12.50% | 2.2M | -0.70 | -A$0.01 | N/A |
Stock Comparison
TTX.AX vs RMD.AX Comparison March 2026
TTX.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TTX.AX stands at 211.2M. In comparison, RMD.AX has a market cap of 48B. Regarding current trading prices, TTX.AX is priced at A$5.09, while RMD.AX trades at A$32.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TTX.AX currently has a P/E ratio of -10.40, whereas RMD.AX's P/E ratio is 23.06. In terms of profitability, TTX.AX's ROE is N/A, compared to RMD.AX's ROE of +0.25%. Regarding short-term risk, TTX.AX is more volatile compared to RMD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for TTX.AX.Check RMD.AX's competition here